iSpecimen (ISPC) Stock Price, News & Analysis

Company Overview

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Key Stats

• Today's Range: $1.13 to $1.17
• 50-Day Range: $1.06 to $1.44
• 52-Week Range: $1.02 to $11.80
• Volume: 17,292 shs
• Average Volume: 416,330 shs
• Market Capitalization: $2.82 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ISPC Stock Analysis - Frequently Asked Questions

How have ISPC shares performed this year?

iSpecimen's stock was trading at $2.65 on January 1st, 2025. Since then, ISPC stock has decreased by 57.4% and is now trading at $1.13.
View the best growth stocks for 2025 here.

How were iSpecimen's earnings last quarter?

iSpecimen Inc. (NASDAQ:ISPC) announced its earnings results on Monday, April, 14th. The company reported ($6.28) EPS for the quarter, missing analysts' consensus estimates of ($4.00) by $2.28. The company earned $1.48 million during the quarter, compared to the consensus estimate of $2.98 million. iSpecimen had a negative net margin of 91.66% and a negative trailing twelve-month return on equity of 139.25%.

When did iSpecimen IPO?

iSpecimen (ISPC) raised $20 million in an initial public offering (IPO) on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

How do I buy shares of iSpecimen?

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of iSpecimen own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iSpecimen investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and Braze (BRZE).

Company Calendar

• Last Earnings: 4/14/2025
• Today: 5/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Commercial physical research
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:ISPC
• CIK: 1558569
• Web: ispecimen.com
• Phone: 781-301-6700
• Fax: N/A
• Employees: 60
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($18.58)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-11,100,000.00
• Net Margins: -91.66%
• Pretax Margin: -91.65%
• Return on Equity: -139.25%
• Return on Assets: -73.97%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.74
• Quick Ratio: 0.74

Sales & Book Value

• Annual Sales: $9.29 million
• Price / Sales: 0.30
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $21.47 per share
• Price / Book: 0.05

Miscellaneous

• Outstanding Shares: 2,497,000
• Free Float: 846,000
• Market Cap: $2.82 million
• Optionable: Not Optionable
• Beta: 1.73